Archived explainer. For the current picture see today's TEM page.
Why Is TEMPUS AI INC A (TEM) Stock Up Today?
By the Top Tier Newswire AI Desk · November 2, 2026 at 12:58 PM ET · reviewed against 18 wire stories
TEMPUS AI INC A (TEM) is up +13.55% in the latest session. Our newswire has captured 18 stories on TEM across 12 sources in the last 36 hours, with AI sentiment reading bullish (avg 64/100).
Public view, delayed 4h. Every headline, price and sentiment read below — and this write-up itself — reaches Pro subscribers live. Public readers see it once it clears the delay.
Tempus AI shares surged 13.55% to close at $82.01, driven by third-quarter results that exceeded expectations and a raised full-year revenue outlook. The stock also benefited from a price target increase by Needham and the completion of regulatory review for its pending acquisition of Personalis.
What Happened
Tempus AI reported third-quarter revenue of $411.5 million, a 23% year-over-year increase, which surpassed analyst estimates. The company posted an adjusted EPS of $0.07 against a consensus estimate of a loss of $0.08. Management raised its full-year 2026 revenue guidance to $1.605 billion. Oncology volume grew 32%, and data licensing bookings reached over $550 million year-to-date. Gross margin expanded to 64.8% from 62.8% in the prior year period. Needham raised its price target to $89 and maintained a Buy rating, citing data growth. The company also cleared regulatory review for its acquisition of Personalis, with a shareholder vote scheduled for November 30. Cathie Wood’s ARK Invest purchased over 154,000 shares ahead of the earnings release.
What The Data Shows
The stock opened at $74.40, a 3.0% gap up from the prior close of $72.22. It reached a session high of $82.10 at 12:55 PM ET and a low of $70.30 at 9:30 AM ET. Trading volume reached 7.6 million shares, which is 1.2 times the three-month daily average. Over the last eight sessions, the stock had already gained 6.6% before this move. The company has a market capitalization of $13.0 billion and remains unprofitable with a trailing twelve-month EPS of -$1.43. Revenue growth over the trailing twelve months stands at 50.4%. The stock has printed 27 fresh 52-week highs and 3 fresh 52-week lows on November 2, 2026. Recent insider activity includes 25 sales totaling $91.6 million in the last 90 days, with no buys. Eric P. Lefkofsky, the CEO, sold shares on October 27, 2026.
What To Watch
Investors will monitor the shareholder vote on the Personalis acquisition scheduled for November 30. The company’s ability to sustain its raised revenue guidance and improve net margins will be key metrics for future performance.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.
Needham raises Tempus AI stock price target to $89 on data growth
Needham raises Tempus AI stock price target to $89 on data growth
7h agoThe Motley FoolBULLISH 74Earnings
Tempus (TEM) Q3 2026 Earnings Call Transcript
Oncology volume surged 32% while data licensing bookings topped $550 million year-to-date.
7h agoThe Motley FoolBULLISH 58Earnings
Tempus AI Revenue Up 23%; Gains Cut Net Loss: Rapid Earnings Reaction
Tempus AI raised its outlook on 23% revenue growth, but most of its smaller net loss came from paper gains on stock it holds, not the core business.
10h agoInvestorsHubBULLISH 74Earnings
Tempus AI Shares Rise 4.18% as Q3 Earnings Beat Forecasts and Revenue Guidance Increases
Tempus AI shares rise 4.18% as Q3 revenue grows 23% to $411.5 million, earnings beat forecasts and FY2026 revenue guidance increases to $1.605 billion.
10h agoInvesting.com MarketsBULLISH 64General
Why is Tempus AI stock rallying today?
Why is Tempus AI stock rallying today?
10h agoStocktwits NewsBULLISH 74Earnings
TEM Stock Jumps On Upbeat Revenue, Raised Outlook — Cathie Wood’s ARK Buys Over 154K Shares Ahead Of Earnings
The company also cleared regulatory review of its pending acquisition of Personalis (PSNL), with a shareholder vote scheduled for November 30.
10h agoBarron'sBULLISH 67Earnings
Tempus AI’s Cancer Screen Business Drives Revenue Up 23%, While a Major Purchase Draws Closer
10h agoGuruFocusBULLISH 74Earnings
Tempus AI (TEM) Reports Record Q3 Revenue, Surpassing Estimates Amid Strong Oncology and Data Growth
Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →